Thermo Fisher Scientific: FDA Approves Ngs-Based Companion Diagnostic for First Targeted Therapy for Patients With Grade 2 Idh-Mutant Glioma
賽默飛世爾:FDA批准面向2級IDH突變膠質瘤患者的首個靶向治療的Ngs基因檢測伴隨診斷
Thermo Fisher Scientific: FDA Approves Ngs-Based Companion Diagnostic for First Targeted Therapy for Patients With Grade 2 Idh-Mutant Glioma
賽默飛世爾:FDA批准面向2級IDH突變膠質瘤患者的首個靶向治療的Ngs基因檢測伴隨診斷
譯文內容由第三人軟體翻譯。